These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34856980)

  • 1. Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study.
    Jin C; Zou K; Xu Y; Yang H; Pan J
    BMC Endocr Disord; 2021 Dec; 21(1):240. PubMed ID: 34856980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated ovarian pentraxin 3 in polycystic ovary syndrome.
    Pan J; Zhou C; Zhou Z; Yang Z; Dai T; Huang H; Jin L
    J Assist Reprod Genet; 2021 May; 38(5):1231-1237. PubMed ID: 33594624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.
    Tosi F; Di Sarra D; Bonin C; Zambotti F; Dall'Alda M; Fiers T; Kaufman JM; Donati M; Franchi M; Zanolin ME; Bonora E; Moghetti P
    Eur J Endocrinol; 2014 Mar; 170(3):401-9. PubMed ID: 24347428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
    Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 as a marker of endothelial dysfunction in young women with polycystic ovary syndrome (PCOS).
    Wyskida K; Franik G; Pohl N; Markuszewski L; Owczarek A; Madej P; Chudek J; Olszanecka-Glinianowicz M
    Scand J Clin Lab Invest; 2019 Oct; 79(6):419-423. PubMed ID: 31282210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
    Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
    Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there differences in basal thrombophilias and C-reactive protein between women with or without PCOS?
    Sánchez-Ferrer ML; Prieto-Sánchez MT; Corbalán-Biyang S; Mendiola J; Adoamnei E; Hernández-Peñalver AI; Carmona-Barnosi A; Salido-Fiérrez EJ; Torres-Cantero AM
    Reprod Biomed Online; 2019 Jun; 38(6):1018-1026. PubMed ID: 31023609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome.
    Demi R İ; Guler A; Alarslan P; Isil AM; Ucman O; Aslanipour B; Calan M
    Endocrine; 2019 Jul; 65(1):175-183. PubMed ID: 31154608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS).
    Christ JP; Falcone T
    Obes Surg; 2018 Aug; 28(8):2171-2177. PubMed ID: 29500679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.